These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
139 related items for PubMed ID: 38400747
1. Therapeutic drug monitoring in pregnancy: Levetiracetam. Fallik N, Trakhtenbroit I, Fahoum F, Goldstein L. Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747 [Abstract] [Full Text] [Related]
2. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study. Kumaravel J, Sarma P, Suri V, Singh P, Prakash A, Medhi B. Neurol India; 2024 Mar 01; 72(2):358-363. PubMed ID: 38691482 [Abstract] [Full Text] [Related]
3. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy. Harby SA, Nassra RA, Mekky JF, Ali SM, Ismail CA. Seizure; 2020 May 01; 78():71-77. PubMed ID: 32213443 [Abstract] [Full Text] [Related]
4. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Voinescu PE, Park S, Chen LQ, Stowe ZN, Newport DJ, Ritchie JC, Pennell PB. Neurology; 2018 Sep 25; 91(13):e1228-e1236. PubMed ID: 30185446 [Abstract] [Full Text] [Related]
5. Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. Pennell PB, Peng L, Newport DJ, Ritchie JC, Koganti A, Holley DK, Newman M, Stowe ZN. Neurology; 2008 May 27; 70(22 Pt 2):2130-6. PubMed ID: 18046009 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics and dosing regimen optimization of levetiracetam in epilepsy during pregnancy. Li Y, Wang ML, Guo Y, Cao YF, Zhao MM, Zhao LM. Br J Clin Pharmacol; 2023 Mar 27; 89(3):1152-1161. PubMed ID: 36260320 [Abstract] [Full Text] [Related]
7. Association of Levetiracetam Concentration With Seizure Frequency in Pregnant Women With Epilepsy. Schelhaas M, Wegner I, Edens M, Wammes-Van Der Heijden E, Touw D, Ter Horst P. Neurology; 2023 Jan 10; 100(2):e172-e181. PubMed ID: 36257713 [Abstract] [Full Text] [Related]
8. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy. Gulcebi MI, Kendirli T, Turgan ZA, Patsalos PN, Onat Yilmaz F. Epilepsy Res; 2018 Dec 10; 148():17-22. PubMed ID: 30326332 [Abstract] [Full Text] [Related]
9. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. Thangaratinam S, Marlin N, Newton S, Weckesser A, Bagary M, Greenhill L, Rikunenko R, D'Amico M, Rogozińska E, Kelso A, Hard K, Coleman J, Moss N, Roberts T, Middleton L, Dodds J, Pullen A, Eldridge S, Pirie A, Denny E, McCorry D, Khan KS. Health Technol Assess; 2018 May 10; 22(23):1-152. PubMed ID: 29737274 [Abstract] [Full Text] [Related]
11. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Reisinger TL, Newman M, Loring DW, Pennell PB, Meador KJ. Epilepsy Behav; 2013 Oct 10; 29(1):13-8. PubMed ID: 23911354 [Abstract] [Full Text] [Related]
16. Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy. Arfman IJ, Wammes-van der Heijden EA, Ter Horst PGJ, Lambrechts DA, Wegner I, Touw DJ. Clin Pharmacokinet; 2020 Apr 10; 59(4):427-445. PubMed ID: 31912315 [Abstract] [Full Text] [Related]
17. A Simulation-Based Assessment of Levetiracetam Concentrations Following Fixed and Weight-Based Loading Doses: A Meta-Regression and Pharmacokinetic Modeling Analysis. Lau A, Haag H, Maharaj A. J Clin Pharmacol; 2024 Sep 10; 64(9):1173-1180. PubMed ID: 38708556 [Abstract] [Full Text] [Related]